Clinical trial
Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis: Interventional, Exploratory Single-center, Randomized, Controlled, Open-label, add-on Study
NCT06874608 is registered in ClinicalTrials.gov with Meyer Children's Hospital IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis: Interventional, Exploratory Single-center, Randomized, Controlled, Open-label, add-on Study
- Lead sponsor
- Meyer Children's Hospital IRCCS
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 12, 2024
- Completion date
- November 15, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
juvenile idiopathic arthritis (jia)